These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30305848)

  • 1. Primary central nervous system lymphoma.
    Löw S; Han CH; Batchelor TT
    Ther Adv Neurol Disord; 2018; 11():1756286418793562. PubMed ID: 30305848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Central Nervous System Lymphoma.
    Han CH; Batchelor TT
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1601-1618. PubMed ID: 29200113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities in primary CNS lymphoma: A systematic review.
    Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
    Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges in the treatment of primary central nervous system lymphoma.
    Yang H; Xun Y; Yang A; Liu F; You H
    J Cell Physiol; 2020 Dec; 235(12):9143-9165. PubMed ID: 32420657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary central nervous system lymphoma: advances in treatment strategies].
    Kondo E
    Rinsho Ketsueki; 2020; 61(5):510-519. PubMed ID: 32507817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Central Nervous System Lymphoma.
    Löw S; Batchelor TT
    Semin Neurol; 2018 Feb; 38(1):86-94. PubMed ID: 29548055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
    Bojic M; Berghoff AS; Troch M; Agis H; Sperr WR; Widhalm G; Wöhrer A; Kalhs P; Preusser M; Rabitsch W
    Eur J Haematol; 2015 Jul; 95(1):75-82. PubMed ID: 25546348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients.
    Garcilazo-Reyes Y; Alentorn A; Duran-Pena A; Hoang-Xuan K; Houillier C
    Curr Treat Options Neurol; 2019 Jul; 21(8):39. PubMed ID: 31324993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis.
    Seidel S; Kowalski T; Nilius-Eliliwi V; Schroers R; Schlegel U
    Neurol Res Pract; 2023 Feb; 5(1):8. PubMed ID: 36814351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Autologous Stem Cell Transplantation a Safe and Effective Alternative to Whole Brain Radiation as Consolidation Therapy in Patients With Primary Central Nervous System Lymphoma?: A Critically Appraised Topic.
    Gritsch D; Mrugala MM; Marks LA; Mangipudi K; Neal M; Wingerchuk DM; O'Carroll CB
    Neurologist; 2021 Jul; 26(4):137-142. PubMed ID: 34190207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the therapy of primary central nervous system lymphoma.
    Plotkin SR; Batchelor TT
    Clin Lymphoma; 2001 Mar; 1(4):263-75; discussion 276-7. PubMed ID: 11707839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective.
    Thomas A; Houillier C; Antoni D; Hoang-Xuan K; Soussain C; Jacob J; Feuvret L
    Rep Pract Oncol Radiother; 2023; 28(2):271-285. PubMed ID: 37456704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the management of primary central nervous system lymphoma.
    Choi YS
    Blood Res; 2020 Jul; 55(S1):S58-S62. PubMed ID: 32719178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance.
    Wang L; Fan Y; Chen B; Zhang J; Yang L; Qiu X; Jiang H; Li J; Xiao X; Huang L; Xu Y
    Front Oncol; 2023; 13():1333761. PubMed ID: 38348121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and treatment of primary central nervous system lymphoma.
    Algazi AP; Kadoch C; Rubenstein JL
    Neurotherapeutics; 2009 Jul; 6(3):587-97. PubMed ID: 19560747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphomas of Central Nervous System.
    Yokogami K; Azuma M; Takeshima H; Hirai T
    Adv Exp Med Biol; 2023; 1405():527-543. PubMed ID: 37452952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.